In August 2022, PrimegeGene announced that Mr. Ye Dong was appointed as the Company's Vice President of Manufacturing & Quality, responsible for the Company's quality assurance and commercial manufacturing management.

Mr. Ye Dong graduated from China Pharmaceutical University majoring in Pharmaceutical Preparation and Nanjing University of Technology with a Master's degree in Pharmaceutical Engineering. Prior to joining PrimegeGene, Mr. Ye worked in Heilongjiang Jumbo Island Pharmaceuticals, Fujian Guangshengtang Pharmaceuticals, and Jiangsu Osaikang Pharmaceuticals, and has more than 20 years of experience in the pharmaceutical industry.

Mr. Ye Dong has experience in the overall management of pharmaceutical manufacturing companies, including drug production management, quality management, technology management, industrialization and technology transfer, and pharmaceutical plant engineering planning and construction. His joining will greatly promote PrimegeGene's commercial production, strictly control the quality control requirements at all stages of the process, and safeguard the company's steady development.

About PrimegeGene

PrimegeGene is a China-based, globally-focused, clinical-stage, innovative pharmaceutical company. The company is committed to becoming a leading international pharmaceutical company by focusing on the discovery, development and commercialization of new drugs for immune/inflammatory diseases and topical drugs to fill unmet clinical needs.

For more information, please visit the official website "https://www.primegene.net".